http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20150096460-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d32a49211015b18ecef5a3a5195bf06e |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7069 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7084 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7092 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485 |
| filingDate | 2013-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1229204194dce1238e61f431002158ec http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2994b905012de132ac1fb1e70eeb29d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e44c1de19b8ce9b6a78c96b6a41064e2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d963a25c616525b2919b95e40f48c370 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe05069eaada20b719f538f68ef9daa7 |
| publicationDate | 2015-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20150096460-A |
| titleOfInvention | Transdermal delivery system |
| abstract | The present invention relates to a method for treating a patient's pain by applying a buprenorphine transdermal therapeutic system for percutaneous administration to the skin of a patient for 7 days, A) a buprenorphine-impermeable backing layer, B) a) polymer base, b) buprenorphine, and c) the buprenorphine is solubilized internally to form a mixture, and wherein the carboxylic acid buprenorphine mixture is selected from the group consisting of oleic acid, linoleic acid, linolenic acid, levulic acid, and linoleic acid in an amount sufficient to form a deposit, Carboxy < / RTI > acid < RTI ID = 0.0 > A buprenorphine-containing matrix layer on said buprenorphine-impermeable backing layer, and C) a skin contact layer on said buprenorphine-containing matrix layer comprising a polymer- Comprising a buprenorphine-containing self-adhesive layer structure, Optionally, the buprenorphine-containing self-adhesive layer structure contains the buprenorphine in an amount of less than 0.8 mg / cm2 of buprenorphine base or an equimolar amount of a pharmaceutically acceptable salt thereof. |
| priorityDate | 2012-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 171.